TFAP2B
Transcription factor AP-2-beta
Also known as: AP-2beta, AP2-B, AP2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92481
- Gene
- TFAP2B
- Ensembl
- ENSG00000008196
- Chromosome
- 6
- Canonical length
- 460 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
460 residues, UniProt reviewed canonical sequence.
>Q92481|TFAP2B
1 MHSPPRDQAA IMLWKLVENV KYEDIYEDRH DGVPSHSSRL SQLGSVSQGP YSSAPPLSHT
61 PSSDFQPPYF PPPYQPLPYH QSQDPYSHVN DPYSLNPLHQ PQQHPWGQRQ RQEVGSEAGS
121 LLPQPRAALP QLSGLDPRRD YHSVRRPDVL LHSAHHGLDA GMGDSLSLHG LGHPGMEDVQ
181 SVEDANNSGM NLLDQSVIKK VPVPPKSVTS LMMNKDGFLG GMSVNTGEVF CSVPGRLSLL
241 SSTSKYKVTV GEVQRRLSPP ECLNASLLGG VLRRAKSKNG GRSLRERLEK IGLNLPAGRR
301 KAANVTLLTS LVEGEAVHLA RDFGYICETE FPAKAVSEYL NRQHTDPSDL HSRKNMLLAT
361 KQLCKEFTDL LAQDRTPIGN SRPSPILEPG IQSCLTHFSL ITHGFGAPAI CAALTALQNY
421 LTEALKGMDK MFLNNTTTNR HTSGEGPGSK TGDKEEKHRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TFAP2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 31 nTPM
- retina: 14 nTPM
- skin: 8.1 nTPM
- kidney: 7.8 nTPM
- breast: 7.7 nTPM
- salivary gland: 6 nTPM
Single-cell type
- retinal amacrine cells: 594 nCPM
- retinal horizontal cells: 377 nCPM
- melanocytes: 231 nCPM
- epididymal principal cells: 147 nCPM
- adrenal medulla cells: 117 nCPM
- loop of henle epithelial cells: 108 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 21 nTPM
- midbrain: 20 nTPM
- medulla oblongata: 8.2 nTPM
- cerebellum: 7.2 nTPM
- thalamus: 2.1 nTPM
- spinal cord: 1.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TFAP2B.
Disease | AllUniProt
Conditions TFAP2B is implicated in, by any mechanism.
- Char syndrome (CHAR) MIM:169100
- Patent ductus arteriosus 2 (PDA2) MIM:617035
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 189 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Char syndrome
- Patent ductus arteriosus 2
- Craniosynostosis syndrome
- Inborn genetic diseases
- Chronic intestinal pseudoobstruction
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.29
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aorta morphogenesis
- collecting duct development
- distal tubule development
- ductus arteriosus closure
- fat cell differentiation
- forelimb morphogenesis
- glucose metabolic process
- hindlimb morphogenesis
- kidney development
- metanephric nephron development
- negative regulation of apoptotic process
- negative regulation of cell population proliferation
- negative regulation of DNA-templated transcription
- negative regulation of neuron apoptotic process
- negative regulation of transcription by RNA polymerase II
- nervous system development
- neuron apoptotic process
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of neuron apoptotic process
- positive regulation of transcription by RNA polymerase II
- regulation of BMP signaling pathway
- regulation of cell differentiation
- regulation of cell population proliferation
- regulation of insulin secretion
- response to xenobiotic stimulus
- retina layer formation
- skin development
- smooth muscle tissue development
- sympathetic nervous system development
- transcription by RNA polymerase II
Molecular functions
- chromatin binding
- cis-regulatory region sequence-specific DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein heterodimerization activity
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transcription factor AP-2
- Transcription factor AP-2, C-terminal
- Transcription factor AP-2
- Transcription factor AP-2 beta
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TFAP2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TFAP2B as an antibody target. Whether an autoantibody or antibody against TFAP2B could matter depends on whether native TFAP2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TFAP2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TFAP2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...